Vaxzevria (previously COVID-19 Vaccine AstraZeneca)-H-C-5675-R-0079
Pharmazeutisch
Vaxzevria (previously COVID-19 Vaccine AstraZeneca)-H-C-5675-R-0079
Fortschrittliche pharmazeutische Formulierung für gezielte therapeutische Intervention.
Dosierung
Vaxzevria (previously COVID-19 Vaccine AstraZeneca)-H-C-5675-R-0079
Stärke
Vaxzevria (previously COVID-19 Vaccine AstraZeneca)-H-C-5675-R-0079
Packungsgröße
Vaxzevria (previously COVID-19 Vaccine AstraZeneca)-H-C-5675-R-0079
Form
Vaxzevria (previously COVID-19 Vaccine AstraZeneca)-H-C-5675-R-0079
Quelle
European Medicines Agency
Sicherheitsprofil
Kontraindikationen
Vaxzevria (previously COVID-19 Vaccine AstraZeneca)-H-C-5675-R-0079
Nebenwirkungen
Vaxzevria (previously COVID-19 Vaccine AstraZeneca)-H-C-5675-R-0079
